Celanese Corporation

AI-generated fair value estimate for this company.

Method: 10-year unlevered FCF DCF: $750M normalized FCF base (vs. $708M TTM, reflecting ongoing cost-cutting); 5% annual FCF growth yrs 1-5 (margin recovery from cyclical trough); 3% yrs 6-10; 8.5% discount rate; 2.25% terminal growth; $11,033M net debt ($12,397M debt vs. $1,364M cash); 109.75M shares outstanding.

Reasoning: Celanese is a mature, cyclical specialty-chemicals producer carrying heavy leverage from its 2022 DuPont M&M acquisition; despite a large reported net loss (driven by non-cash impairments), underlying FCF generation remains solid, but the large net debt load caps intrinsic equity value and justifies a higher discount rate reflecting credit/balance-sheet risk.